Honorary President of Yantai YEDA International Incubator for Biomedical Innovation (Hereinafter referred to as "YETDA BioPark"). From 2007 to 2017 he was the Vice President of research in the University of Alberta, Canada. He is a fellow for Royal Society of Canada, Canadian Academy of Health Sciences, Royal College of Physicians and Surgeons Canada, European Academy of Science, American National Academy of Inventors, Order of Canada,etc. He has outstanding achievements in biomedical research, public health, biotechnology and other fields, and has many awards and honors received from all over the world.A world leading figure in health science, he has won the Arts Council of Canada Killam award, the Queen Elizabeth Ⅱ diamond memorial medal and over 50 other Canadian and international awards, Including the 2016 GCHERA world agriculture award in China. In addition, professor Babiuk has been recognized as one of the 1000 international scientific leaders.

“I’ve had extensive experience in linking academia to industry and translating discoveries from the laboratory to commercial applications.”

“I have served on many national and international organizations involved in both developing collaborative networks as well as helping set government policy. I have been a consultant and sat on the board of companies and other organizations helping formulate strategies for success. I’m able to bring all this experience to YETDA BioPark . This experience will help to develop a plan for the incubator to capture the global trends of biomedical R&D such that YETDA BioPark will become one of the leading incubators and economic engines in the region and nationally.”

“I would like to enhance the connection between YETDA BioPark and various North American and European research institutes, research networks and companies to co-develop products.”

“I will work to identify global experts to review the projects most likely to succeed and to identify the ones with most economic benefits locally and globally. In this regard, we will also link with global incubators and both learn from each other but more importantly, co-develop technologies for exploitation globally. This would enhance the commercialization potential of the products developed.”

Master of Molecular Virology, China Food and Drug Administration, and Doctor of Molecular Virology, Canadian Vaccine and Infectious Disease Research Center (VIDO).He worked in the world-renowned drug R&D companies such as the Johnson & Johnson (JNJ) Pharmaceutical Research Institute, CELL GENESYS, VERTEX Pharmaceuticals and others for nearly 20 years and has extensive experience in the fields of biopharmaceutical and small molecule drug development, in vitro / in vivo tumor models and pharmacology research, viral infection and antigen expression mechanisms, Promoted multiple drugs into clinical research. Published more than 30 academic papers and holds many international patents, He can provide professional guidance for innovative drug cooperative research and project R & D development and management.

The recent years have marked a historical period in Chinese history regarding rapid progress in innovation. The strong support from state and local governments have provided exceptional opportunities for scientific and technological innovation.Combined with local advantages,we will focus on biomedical innovation and envision developing an excellent industrial development environment to foster innovative biomedical enterprises. Through the establishment of a specialized biomedical incubator with abundant resources, we are attracting global projects with the best development potential. By providing strong financial support, with full guidance of enterprise growth for rapid appreciation, we will help these innovative enterprises  enter the industrialization path quickly and achieve the goal of rapid growth.